SEC Form 4 · accession 0001104659-18-021007
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Mary Z. Luo
Officer — COO Chief Scientist & Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Scientific Officer · Director · 10% Owner
Period of report
Mar 26, 2018
Accepted (ET)
Mar 28, 2018 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 26, 2018 | F | 20,728 | $18.61 | D | 2,040,619 | D | |
| Common StockF1,F2 | Mar 26, 2018 | F | 8,844 | $18.61 | D | 1,346,129 | I | See footnote |
| Common StockF3 | holding | — | — | — | 7,461,594 | I | See footnote | |
| Common StockF4 | holding | — | — | — | 5,000 | I | See footnote | |
| Common StockF5 | holding | — | — | — | 200,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
- F2The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
- F3The shares are held of record by APCL, of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust (the "BLZ Trust") are the sole owners.
- F4The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
- F5The shares are held of record by the BLZ Trust. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.